Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

LIMPRINT: Prevalence of Chronic Edema in Health Services in Copenhagen, Denmark

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. LIMPRINT: Estimation of the Prevalence of Lymphoedema/Chronic Oedema in Acute Hospital in In-Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. LIMPRINT: The UK Experience-Subjective Control of Swelling in Patients Attending Specialist Lymphedema Services

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and Turkey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Prevalence and Risk Factors for Chronic Edema in U.K. Community Nursing Services

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clinical and Ethical Challenges in Undertaking LIMPRINT in Vulnerable Populations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. LIMPRINT: Estimation of the Prevalence of Lymphoedema/Chronic Oedema in Acute Hospital in In-Patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. LIMPRINT: The UK Experience-Subjective Control of Swelling in Patients Attending Specialist Lymphedema Services

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: The International Lymphedema Framework developed an international study, Lymphedema Impact and Prevalence International (LIMPRINT), to estimate the prevalence and impact of chronic edema (CO) in heterogeneous populations. Methods and Results: A validation study using the LIMPRINT methodology was undertaken in Denmark. Participants with CO were identified from inpatient services and compared with those identified within a specialist lymphedema service and three primary care settings. Of 452 inpatients available for screening, CO was present in 177 (39%) and absent in 275 (61%). In addition, 723 participants were found from specialist and primary care services (LPCSs). Inpatients were significantly older and more likely to be underweight or normal weight. They were more likely to suffer from heart failure/ischaemic heart disease (44.6% vs. 23.4%, p < 0.001) and have neurological problems (18.1% vs. 10.9% p = 0.009). Patients in the inpatient group were nearly all suffering from secondary lymphedema and were less likely to have a cancer or venous diagnosis, but more likely to have immobility as the cause of CO (44.0% vs. 17.7%, p < 0.001). No inpatients had midline CO compared with 30 within LPCSs. Fewer in the inpatient group had standard CO treatment (17.1% vs. 73.5%, p < 0.001) and subjective control of swelling was worse (19.9% vs. 66.7%, p < 0.001). While the inpatient group experienced fewer acute infections, when they did so, they were more likely to be admitted to hospital for this (78.6% vs. 51.0%, p = 0.049). Conclusion: The prevalence of CO in inpatient facilities is high and those with CO have multiple comorbidities that vary according to setting. The feasibility study showed that the methodology could be adapted for use in different health systems.

OriginalsprogEngelsk
TidsskriftLymphatic Research and Biology
Vol/bind17
Udgave nummer2
Sider (fra-til)187-194
Antal sider8
ISSN1539-6851
DOI
StatusUdgivet - apr. 2019

ID: 59164901